Sasken Technologies SASKEN

Summary

Sasken is a Bengaluru-headquartered product-engineering company describing its own work as "chip-to- cognition R&D services," reporting through Software Services and Product Solutions segments across semiconductor, automotive, industrial and satellite-communications clients. Its most AI-relevant recent development is a disclosed FY26 win of "a strategic semiconductor engagement with an emerging AI silicon innovator to lead full-chip analog and mixed-signal circuit design for next-generation AI SoCs on advanced 12nm process technology" — a genuine, if unnamed-client, AI-chip-design contract. Q1 FY27 management commentary explicitly linked growth to "AI and silicon demand," with new contract bookings of $47.1 million in the quarter.

The scale of Sasken's recent growth, however, is substantially a function of the April 2025 completion of its acquisition of Borqs Technologies' ODM/software business (~$40 million purchase price) rather than organic AI-silicon demand alone: FY26 consolidated revenue grew 102% YoY to ₹1,113 crore, but management's own disclosure attributes this to "27.4% organic growth in strategic accounts" plus the acquisition's first full-year contribution — meaning roughly three-quarters of the reported growth rate is inorganic. EBITDA margin, even after this scale increase, remains thin at 7.9-9.9%, well below the high-teens margins LTTS and (pre-decline) Cyient report, and ROE stands at just 7.0%.

Governance has also shown a recurring, if financially minor, friction pattern: Sasken disclosed three separate BSE/NSE penalty notices between November 2025 and March 2026 (cumulatively ~₹23 lakh) for alleged board/committee-composition non-compliance under SEBI LODR, disputing each while applying for fee waivers. Sell-side analyst coverage is essentially absent — the only indexed formal brokerage report found in this research is a thirteen-year-old, long-superseded ICICI Securities note.

Net: a HOLD. The AI-silicon design win and the broader "60x4x3" growth strategy are genuine positives, but thin margins, low return on equity, an inorganic growth base, and recurring minor governance friction mean this report cannot yet justify paying today's ~35x multiple on the strength of one disclosed design win.

• A genuine, disclosed AI-silicon design win. The FY26 engagement to lead full-chip analog and mixed-signal design for next-generation AI SoCs on 12nm process technology, for an unnamed "emerging AI silicon innovator," is a real, if not-yet-sized, entry into AI-chip design work.
• A three-decade semiconductor-services track record underpins the credibility of this win — Sasken is not a new entrant chasing an AI-hype label.
• Strong recent bookings momentum. $47.1 million of new contract bookings in Q1 FY27 (₹339 crore quarterly revenue), with management explicitly linking growth to "AI and silicon demand."
• An explicit, disclosed strategy to reduce customer concentration. The "60x4x3" plan (60 marquee accounts to $4M+ revenue each within three years) directly targets a structural risk this report's research confirmed has fallen materially over the years (top-2 customer concentration down from ~50% in FY09 to ~17% by FY25).
• A debt-free capital structure and a rising FY26 dividend (₹25/share cumulative).
• The Borqs acquisition adds real IoT/5G/connected-device capability, not merely revenue — diversifying the company's addressable engineering-services base.

• Most of FY26's headline growth was inorganic. Of the reported 102% YoY revenue growth, management's own commentary attributes only 27.4% to organic strategic-account growth — the remainder is the Borqs acquisition's first full-year contribution, not underlying AI-silicon demand acceleration.
• Margins remain thin relative to peers. FY26 EBITDA margin of 7.9-9.9% is well below the high-teens margins reported by LTTS and Cyient (pre-decline), and ROE of just 7.0% is the lowest disclosed among this report's eight companies.
• No disclosed percentage of revenue is specifically semiconductor/chip-design-related — only qualitative "key vertical" language and the one named-but-unidentified AI-silicon engagement.
• A recurring pattern of minor LODR governance penalties. Three separate BSE/NSE fines (November 2025, February 2026, March 2026) for alleged board/committee-composition non-compliance, cumulatively modest (~₹23 lakh) but repeated three times within five months — a pattern worth flagging even though the company disputes each instance.
• Sell-side coverage is essentially absent. The only indexed formal brokerage report found is a 2013 ICICI Securities note, more than a decade stale — this report could not find any current, verifiable named analyst target price.
• Order-book disclosure is internally inconsistent — a "$35.4 million FY26 order book" figure and a "$172.7 million FY26 cumulative bookings" figure appear to describe different things without clear labelling in the sources this research reached.

• Any disclosure of a standalone semiconductor/AI-design revenue percentage.
• Resolution of the three disputed LODR penalty notices, and whether further notices follow.
• Clarification of the order-book vs. cumulative-bookings figures in the next investor presentation.

• Growth-quality risk (dominant). The bulk of recent growth is acquisition-driven, not organic AI-silicon demand, and this report's rating reflects that distinction.
• Margin risk given thin EBITDA margins relative to peers.
• Governance-friction risk from the recurring LODR penalty pattern.
• Coverage/liquidity risk given the essentially absent sell-side analyst base.

At a disclosed trailing P/E of 35.4x and CMP of ₹1,720, implied trailing EPS is ~₹48.6. Applying an indicative 15% forward-growth assumption (moderated from the Q1 FY27 YoY surge, which reflected a low prior-year base) gives a constructed FY27E EPS of ~₹55.9. We apply a target multiple band modestly below the current trailing multiple, reflecting the thin margins and low ROE relative to the multiple being paid:

Base case rounded to ₹1,677. No current, verifiable named-brokerage target exists for cross-check — the only formal report this research located (ICICI Securities, 2013) is too stale to be usable. This valuation should be treated as this report's own independent construction, without the benefit of a sell-side consensus to triangulate against.

Source: screener.in (18 Sep 2026), cross-checked against Whalesbook/CXOToday FY26 results coverage.